Harvard Bioscience Faces Delisting Concerns

Ticker: HBIO · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1123494

Harvard Bioscience Inc 8-K Filing Summary
FieldDetail
CompanyHarvard Bioscience Inc (HBIO)
Form Type8-K
Filed DateJun 23, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

Related Tickers: HBIO

TL;DR

HBIO might be delisted - big trouble ahead.

AI Summary

Harvard Bioscience, Inc. filed an 8-K on June 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The report was filed as of June 23, 2025, with the earliest event reported on June 18, 2025. The company is incorporated in Delaware and its principal executive offices are located at 84 October Hill Road, Holliston, MA.

Why It Matters

This filing indicates potential issues with Harvard Bioscience's continued listing on an exchange, which could significantly impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's operations and stock value.

Key Players & Entities

  • HARVARD BIOSCIENCE, INC. (company) — Registrant
  • June 18, 2025 (date) — Earliest event reported
  • June 23, 2025 (date) — Filing date
  • Delaware (jurisdiction) — State of Incorporation
  • 84 October Hill Road, Holliston, MA 01746 (address) — Principal Executive Offices

FAQ

What specific listing rule or standard has Harvard Bioscience, Inc. failed to satisfy?

The filing states a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.

What is the date of the earliest event reported in this 8-K filing?

The earliest event reported is dated June 18, 2025.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted as of June 23, 2025.

In which state is Harvard Bioscience, Inc. incorporated?

Harvard Bioscience, Inc. is incorporated in Delaware.

What is the company's principal executive office address?

The principal executive offices are located at 84 October Hill Road, Holliston, MA 01746.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.